We'll commence our 119th meeting of the Standing Committee on Health. We're going to continue our study on barriers to access treatment and drugs for Canadians affected by rare diseases and disorders.
Today, we have two panels. The first panel has two organizations, and then at 10:10 or so, we're going to have the Department of Health come in.
In our first panel, we have Erin Little, the president of the Liv-A-Little Foundation. Welcome. From the atypical Hemolytic Uremic Syndrome Canada, we have Mary Jane Vowles and Caryn Vowles, board members. Welcome.
I'm going to invite Ms. Little to make a 10-minute opening statement.